Download file, English (1 MB PDF) - RHO
Download file, English (1 MB PDF) - RHO
Download file, English (1 MB PDF) - RHO
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2.1. Is there a government funded HPV<br />
vaccination program?<br />
2.2. Is there any agency or nongovernmental<br />
organization that has begun demonstration<br />
projects for HPV vaccine introduction in some<br />
regions of your country?<br />
If yes, please specify:<br />
2. PRIMARY PREVENTION: HPV VACCINATION<br />
Yes<br />
No<br />
Yes<br />
No<br />
2.3. If there is not national HPV vaccination<br />
Yes<br />
program, is there intention to start one?<br />
No<br />
If yes, indicate needs identified for the introduction process:<br />
3. SECONDARY PREVENTION:<br />
SCREENING FOR AND TREATMENT OF PRECANCEROUS LESIONS<br />
3.1. What screening methods are<br />
included in your country’s cervical<br />
cancer prevention and control<br />
program?<br />
Cytology (Pap smear)<br />
Visual inspection with acetic acid (VIA)<br />
HPV DNA test<br />
SCREENING METHOD<br />
CYTOLOGY<br />
VISUAL<br />
INSPECTION<br />
HPV DNA TEST<br />
3.2. What is the age of the target<br />
population?<br />
3.3. How often is screening<br />
recommended?<br />
3.4. What is the screening<br />
coverage? What is the<br />
coverage objective established<br />
by the program?<br />
Coverage:<br />
Objective:<br />
Coverage:<br />
Objective:<br />
Coverage:<br />
Objective:<br />
3.5. What percentage of women<br />
with precancerous lesions have<br />
received treatment?<br />
Comments:<br />
Report of an African Regional Meeting on Cervical Cancer: September 2010 79
Change language